BioXcel Therapeutics Inc - BTAI - stock price prediction, stock price target, analyst ratings from 5 analysts

BioXcel Therapeutics Inc has a share price target of US$ 20, revenue growth forecast of -68.3%, and profit growth estimate of 12.7% for FY25, based on top 5 analyst calls.